Skip to content

The effect of leech therapy on carpal tunnel syndrome

A comparison between leech therapy and medical treatment on clinical symptoms severity as well as nerve and muscle cord changes of patients with carpal tunnel syndrome in moderate grade.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180909040977N1
Enrollment
60
Registered
2019-01-08
Start date
2018-11-22
Completion date
Unknown
Last updated
2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of leech therapy on Nerve condition in carpal tunnel syndrome patients. Other lesions of median nerve

Interventions

Intervention 1: Intervention group: In the intervention group, the patient uses leech therapy in addition to receiving medical treatment (Tablets of Celecoxib 100 mg twice daily, Gabapentin 100 mg twi
300 mg once daily for one month, using short cock-up splint, which should be used at bedtime). Leech therapy will be implemented once, on the first day and in the absence of improvement of pain and cl
300 mg once daily for one month, plus a short cock up splint during sleep will be received.

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: The presence of clinical symptoms and having positive Tinel, Fallen and carpal compersion tests Having positive paraclinical findings (nerve conduction velocity and electromyography) detected by electrodiagnosis and the grades must be in intermediate level by neurologist and neurologist specialist diagnosis. Satisfaction should be gained by the use of one of two methods. Age between 30-60 years

Exclusion criteria

Exclusion criteria: The presence of rheumatic disease, rheumatoid arthritis and other upper limb disorders, coagulation problems, diabetes, hypothyroidism, gout, lupus erythematosus, acromegaly, chronic kidney failure, and diseases that impede CTS symptoms. Pregnancy for up to a year and mental retardation and anemia Frequent fracture or trauma to the wrist and wrist surgery Injection of intra-articular corticosteroid in the wrists during the past 3 months Immune system disorders, severe allergic allergy, use of neuropathic drugs, use of non-steroidal anti-inflammatory drugs during the last two weeks History of stroke syndrome

Design outcomes

Primary

MeasureTime frame
Abnormalities in electromyography and nerve study. Timepoint: Once on the first day of the study and once on day 60. Method of measurement: Electromyographic machine Nihon kohden model.;Pain score on the analog scale visual pain. Timepoint: In 4 steps, at the beginning of the study (before treatment or leech therapy), on day 15, day 30 and day. Method of measurement: Visual Analogue Scale.;Severity of symptoms and functional status. Timepoint: In 4 stages, at the time of entering the study (before treatment or leech therapy), on day 15, day 30 and day 60. Method of measurement: Boston Clinical Symptom Intensity Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli akbar Aghaeinejad

Gorgan University of Medical Sciences

dr.aghaeinejad@goums.ac.ir+98 17 3245 1664

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026